|
|
Article: CANTAB PHARMACEUTICALS SIGNS AGREEMENT WITH OXFORD UNIVERSITY AND REPORTS ON COLLABORATION WITH UNIVERSITY COLLEGE LONDON
- Article from:
- PR Newswire
- Article date:
- May 4, 1993
CopyrightCOPYRIGHT 1993 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CAMBRIDGE, England, May 4 /PRNewswire/ -- Cantab Pharmaceuticals plc (NASDAQ: CNTBY) today announced that it has signed a two-year agreement with the University of Oxford. The agreement gives Cantab an option to acquire rights to certain inventions in the area of T-cell receptors for human therapy. Cantab's scientists will assist with the identification and protection of proprietary products and technology emerging from research carried out in some of the University's clinical research laboratories.
The agreement allows Cantab to assist certain University researchers in filing patent applications relating to their inventions and in return will gain options to ...